Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In the SURMOUNT-1 trial , adults with obesity or overweight (without diabetes) taking tirzepatide achieved up to 22.5% average body weight reduction at 72 weeks
Ongoing communication , medical oversight, and personalized care help ensure treatment stays safe, effective, and aligned with each patients health goals
Reta Pen 40mg is supported by Janoshik third-party testing, with the test report available for researchers, laboratories and procurement buyers to review
Excessive foam that does not dissipate, or foam that reappears after settling, suggests the peptide has been denatured (damaged)
US$ 24.98
US$ 27.61
US$ 21.68
